GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (LTS:0A7L) » Definitions » Debt-to-Revenue

iRhythm Technologies (LTS:0A7L) Debt-to-Revenue : 1.12 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is iRhythm Technologies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

iRhythm Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $15.9 Mil. iRhythm Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $721.0 Mil. iRhythm Technologies's annualized Revenue for the quarter that ended in Dec. 2024 was $657.3 Mil. iRhythm Technologies's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 1.12.


iRhythm Technologies Debt-to-Revenue Historical Data

The historical data trend for iRhythm Technologies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Debt-to-Revenue Chart

iRhythm Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.37 0.32 0.26 1.25

iRhythm Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 1.40 1.24 1.25 1.12

Competitive Comparison of iRhythm Technologies's Debt-to-Revenue

For the Medical Devices subindustry, iRhythm Technologies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRhythm Technologies's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where iRhythm Technologies's Debt-to-Revenue falls into.


;
;

iRhythm Technologies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

iRhythm Technologies's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(15.867 + 721.042) / 591.839
=1.25

iRhythm Technologies's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(15.867 + 721.042) / 657.3
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


iRhythm Technologies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


iRhythm Technologies Business Description

Traded in Other Exchanges
Address
699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

iRhythm Technologies Headlines

No Headlines